The independent and combined effects of lifetime smoke exposures and asthma as they relate to COPD

Expert Review of Respiratory Medicine

Volumn 8, Issue 4, 2014, Pages 503-514

  Perret, Jennifer L ^a,b,c   Walters, Eugene H ^d,e   Abramson, Michael J ^f,g   McDonald, Christine F ^b,c   Dharmage, Shyamali C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HOSPITAL   (Australia)

^c Institute for Breathing and Sleep (IBAS)   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

^e UNIVERSITY OF NOTRE DAME   (Australia)

^f MONASH UNIVERSITY   (Australia)

^g ALFRED HOSPITAL   (Australia)

Author keywords

Active smoking; Asthma; COPD; Interaction; Lung function; Second hand smoke; Tobacco

Indexed keywords

CIGARETTE SMOKE; NICOTINE; PASSIVE SMOKING;

AIRWAY OBSTRUCTION; ASTHMA; ATOPY; ATTRIBUTABLE RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL RESEARCH; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FORCED EXPIRATORY VOLUME; HUMAN; HYPOTHESIS; LIFESPAN; LUNG CANCER; LUNG FUNCTION; LUNG FUNCTION TEST; MATERNAL SMOKING; MEDICAL SUBJECT HEADINGS; MEDLINE; MORTALITY; PARENTAL SMOKING; PASSIVE SMOKING; PATHOPHYSIOLOGY; PUBLIC HEALTH; REVIEW; RISK FACTOR; SEX DIFFERENCE; SMOKE; SMOKING; SPIROMETRY; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; ADVERSE EFFECTS; COMPLICATION; LUNG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ASTHMA; HUMANS; LUNG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 84904282480     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/17476348.2014.905913     Document Type: Review

References (105)

1. World Health Organization. Tobacco. Fact sheet No339. Updated July 2013. Available from: www.who.int/mediacentre/factsheets/fs339/en/#
2. GBD 2004 Summary Tables. Health statistics and informatics Department, World Health Organization. Geneva, Switzerland;2008
3. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370(9589): 741-50
4. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: updated. 2013
5. Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated. 2010
6. Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;182(5): 693-718 •• Provides comprehensive summaries of the evidence relating to potential COPD risk factors.
7. Lange P. Persistent airway obstruction in asthma. Am J Respir Crit Care Med 2013; 187(1): 1-2
8. de Marco R, Accordini S, Marcon A, et al. Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am J Respir Crit Care Med 2011;183(7): 891-7
9. Travers J, Marsh S, Williams M, et al. External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Thorax 2007;62(3): 219-23
10. Beasley R, Weatherall M, Travers J, Shirtcliffe P. Time to define the disorders of the syndrome of COPD. Lancet 2009; 374(9691): 670-2
11. Perret JL, Dharmage SC, Matheson MC, et al. The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age. Am J Respir Crit Care Med 2013;187(1): 42-8 •• Describes a three-way interaction, and the association between asthma and spirometrically defined COPD in terms of pack-years of smoking.
12. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26(5): 948-68
13. Quanjer PH, Enright PL, Miller MR, et al. The need to change the method for defining mild airway obstruction. Eur Respir J 2011;37(3): 720-2
14. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012;40(6): 1324-43
15. Vaz Fragoso CA, Concato J, McAvay G, et al. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181(5): 446-51
16. Toelle BG, Xuan W, Bird TE, et al. Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) study. Med J Aust 2013; 198(3): 144-8
17. Bridevaux PO, Gerbase MW, Probst-Hensch NM, et al. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax 2008;63(9): 768-74
18. Svanes C, Omenaas E, Jarvis D, et al. Parental smoking in childhood and adult obstructive lung disease: results from the European Community Respiratory Health Survey. Thorax 2004;59(4): 295-302
19. Bridevaux PO, Probst-Hensch NM, Schindler C, et al. Prevalence of airflow obstruction in smokers and never-smokers in Switzerland. Eur Respir J 2010;36(6): 1259-69
20. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011;365(17): 1567-75
21. Hogg JC, McDonough JE, Gosselink JV, Hayashi S. What drives the peripheral lung-remodeling process in chronic obstructive pulmonary disease? Proc Am Thorac Soc 2009;6(8): 668-72
22. Sciurba FC. Physiologic similarities and differences between COPD and asthma. Chest 2004;126(2 Suppl): 117S-24S; discussion 159S-161S
23. Hogg JC. Lung structure and function in COPD. Int J Tuberc Lung Dis 2008;12(5): 467-79
24. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350(26): 2645-53
25. Sinden NJ, Stockley RA. Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence. Thorax 2010;65(10): 930-6
26. Milara J, Peiro T, Serrano A, Cortijo J. Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax 2013; 68(5): 410-20
27. Sohal SS, Ward C, Danial W, et al. Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease. Expert Rev Respir Med 2013;7(3): 275-88
28. Geraghty P, Hardigan AA, Wallace AM, et al. The glutathione peroxidase 1-protein tyrosine phosphatase 1B-protein phosphatase 2A axis. A key determinant of airway inflammation and alveolar destruction. Am J Respir Cell Mol Biol Nov 2013;49(5): 721-30
29. Narang I, Bush A. Early origins of chronic obstructive pulmonary disease. Semin Fetal Neonatal Med 2012;17(2): 112-18
30. Abel EL. Smoking during pregnancy: a review of effects on growth and development of offspring. Hum Biol 1980; 52(4): 593-625
31. Crane JM, Keough M, Murphy P, et al. Effects of environmental tobacco smoke on perinatal outcomes: a retrospective cohort study. BJOG 2011;118(7): 865-71
32. Office on Smoking and Health (US). The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2006. 5, Reproductive and Developmental Effects from Exposure to Secondhand Smoke. Available from: www.ncbi.nlm.nih. gov/books/NBK44317/
33. Sekhon HS, Keller JA, Benowitz NL, Spindel ER. Prenatal nicotine exposure alters pulmonary function in newborn rhesus monkeys. Am J Respir Crit Care Med 2001;164(6): 989-94
34. Hanrahan JP, Tager IB, Segal MR, et al. The effect of maternal smoking during pregnancy on early infant lung function. Am Rev Respir Dis 1992;145(5): 1129-35
35. Landau LI. Tobacco smoke exposure and tracking of lung function into adult life. Paediatr Respir Rev 2008;9(1): 39-43; quiz 43-34
36. Pulmonary pathophysiology. 8th edition. Lippincott; Williams & Wilkins; 2013. West JB, Kelly P.J.
37. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008;8(3): 183-92
38. James AL, Elliot JG, Jones RL, et al. Airway smooth muscle hypertrophy and hyperplasia in asthma. Am J Respir Crit Care Med 2012;185(10): 1058-64
39. Thomson NC, Chaudhuri R. Asthma in smokers: challenges and opportunities. Curr Opin Pulm Med 2009;15(1): 39-45 •• Discusses clinical aspects, pathological mechanisms and the limited evidence available for optimal drug treatment.
40. Pride NB, Ingram RH Jr, Lim TK. Interaction between parenchyma and airways in chronic obstructive pulmonary disease and in asthma. Am Rev Respir Dis 1991;143(6): 1446-9
41. Kinsella M, Muller NL, Staples C, et al. Hyperinflation in asthma and emphysema. Assessment by pulmonary function testing and computed tomography. Chest Aug 1988;94(2): 286-9
42. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339(17): 1194-200
43. Perret JL, Burgess JA, Dharmage SC, et al. TAHS unpublished data. The University of Melbourne. 2013
44. Chaudhuri R, McSharry C, McCoard A, et al. Role of symptoms and lung function in determining asthma control in smokers with asthma. Allergy 2008;63(1): 132-5
45. Chinn S, Jarvis D, Luczynska CM, et al. An increase in bronchial responsiveness is associated with continuing or restarting smoking. Am J Respir Crit Care Med 2005; 172(8): 956-61
46. Lazarus SC, Chinchilli VM, Rollings NJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007;175(8): 783-90
47. Chaudhuri R, Livingston E, McMahon AD, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006;174(2): 127-33
48. Polosa R, Russo C, Caponnetto P, et al. Greater severity of new onset asthma in allergic subjects who smoke: a 10-year longitudinal study. Respir Res 2011;12: 16
49. Comhair SA, Gaston BM, Ricci KS, et al. Detrimental effects of environmental tobacco smoke in relation to asthma severity. PLoS One 2011;6(5):e18574
50. Sims M, Maxwell R, Gilmore A. Short-term impact of the smokefree legislation in England on emergency hospital admissions for asthma among adults: a population-based study. Thorax 2013; 68(7): 619-24
51. Jones LL, Hashim A, McKeever T, et al. Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: systematic review and meta-analysis. Respir Res 2011;12: 5
52. Custovic A, Marinho S, Simpson A. Gene-environment interactions in the development of asthma and atopy. Expert Rev Respir Med 2012;6(3): 301-8
53. Marinho S, Custovic A, Marsden P, et al. 17q12-21 variants are associated with asthma and interact with active smoking in an adult population from the United Kingdom. Ann Allergy Asthma Immunol 2012;108(6): 402-11; e409
54. Bukvic BK, Blekic M, Simpson A, et al. Asthma severity, polymorphisms in 20p13 and their interaction with tobacco smoke exposure. Pediatr Allergy Immunol 2013;24(1): 10-18
55. Silverman EK, Vestbo J, Agusti A, et al. Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report. COPD 2011; 8(2): 121-35
56. ten Brinke A, Zwinderman AH, Sterk PJ, et al. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 2001;164(5): 744-8
57. Brown PJ, Greville HW, Finucane KE. Asthma and irreversible airflow obstruction. Thorax 1984;39(2): 131-6 • First clear documentation of this long-term sequel for asthma.
58. Vonk JM, Jongepier H, Panhuysen CI, et al. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 2003;58(4): 322-7
59. Connolly CK, Prescott RJ. The Darlington and Northallerton long term asthma study: pulmonary function. BMC Pulm Med 2005;5: 2
60. Stern DA, Morgan WJ, Halonen M, et al. Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet 2008;372(9643): 1058-64
61. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368(9537): 804-13
62. Miranda C, Busacker A, Balzar S, et al. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004;113(1): 101-8
63. Bush A, Menzies-Gow A. Phenotypic differences between pediatric and adult asthma. Proc Am Thorac Soc 2009;6(8): 712-19
64. Essilfie AT, Simpson JL, Dunkley ML, et al. Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax 2012;67(7): 588-99
65. Shirtcliffe P, Marsh S, Travers J, et al. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease. Intern Med J 2012;42(1): 83-8
66. Haldar P, Pavord ID. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol 2007; 119(5): 1043-52; quiz 1053-1044
67. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003;362(9387): 847-52
68. Kohansal R, Martinez-Camblor P, Agusti A, et al. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 2009;180(1): 3-10
69. Knudson RJ, Slatin RC, Lebowitz MD, Burrows B. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis 1976;113(5): 587-600
70. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1(6077): 1645-8
71. Higgins MW, Enright PL, Kronmal RA, et al. Smoking and lung function in elderly men and women. The Cardiovascular Health Study. JAMA 1993;269(21): 2741-8
72. Vestbo J, Hogg JC. Convergence of the epidemiology and pathology of COPD. Thorax 2006;61(1): 86-8
73. Woolcock AJ, Peat JK, Leeder SR, Blackburn CRB. The development of lung function in Sydney children: effects of respiratory illness and smoking. A ten year study. Eur J Respir Dis Suppl 1984;132: 1-137
74. Taylor R, Najafi F, Dobson A. Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. Int J Epidemiol 2007;36(5): 1048-59
75. Burke H, Leonardi-Bee J, Hashim A, et al. Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics 2012; 129(4): 735-44
76. Keil T, Lau S, Roll S, et al. Maternal smoking increases risk of allergic sensitization and wheezing only in children with allergic predisposition: longitudinal analysis from birth to 10 years. Allergy 2009;64(3): 445-51 • Important interaction that provides a potential mechanism by which maternal smoking increases the risk of childhood asthma.
77. Moshammer H, Hoek G, Luttmann-Gibson H, et al. Parental smoking and lung function in children: an international study. Am J Respir Crit Care Med 2006;173(11): 1255-63
78. Gilliland FD, Berhane K, Li YF, et al. Effects of early onset asthma and in utero exposure to maternal smoking on childhood lung function. Am J Respir Crit Care Med 2003;167(6): 917-24 • Describes the interplay between prenatal maternal smoking, asthma and gender on childhood lung function.
79. Gilliland FD, Berhane K, McConnell R, et al. Maternal smoking during pregnancy, environmental tobacco smoke exposure and childhood lung function. Thorax 2000; 55(4): 271-6
80. Tager IB, Weiss ST, Munoz A, et al. Longitudinal study of the effects of maternal smoking on pulmonary function in children. N Engl J Med 1983;309(12): 699-703
81. Rizzi M, Sergi M, Andreoli A, et al. Environmental tobacco smoke may induce early lung damage in healthy male adolescents. Chest 2004;125(4): 1387-93
82. Lovasi GS, Diez Roux AV, Hoffman EA, et al. Association of environmental tobacco smoke exposure in childhood with early emphysema in adulthood among nonsmokers: the MESA-lung study. Am J Epidemiol 2010;171(1): 54-62
83. Svanes C, Sunyer J, Plana E, et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2010;65(1): 14-20
84. Sherrill DL, Martinez FD, Lebowitz MD, et al. Longitudinal effects of passive smoking on pulmonary function in New Zealand children. Am Rev Respir Dis 1992; 145(5): 1136-41
85. Rona RJ, Chinn S. Lung function, respiratory illness, and passive smoking in British primary school children. Thorax 1993;48(1): 21-5
86. Hayatbakhsh MR, Sadasivam S, Mamun AA, et al. Maternal smoking during and after pregnancy and lung function in early adulthood: a prospective study. Thorax 2009;64(9): 810-14
87. Upton MN. Effects of parental smoking on the respiratory health of adults. Thorax 2004;59(4): 274-6
88. Goodman P, Agnew M, McCaffrey M, et al. Effects of the Irish smoking ban on respiratory health of bar workers and air quality in Dublin pubs. Am J Respir Crit Care Med 2007;175(8): 840-5
89. White JR, Froeb HF. Small-airways dysfunction in nonsmokers chronically exposed to tobacco smoke. N Engl J Med 1980;302(13): 720-3
90. Masi MA, Hanley JA, Ernst P, Becklake MR. Environmental exposure to tobacco smoke and lung function in young adults. Am Rev Respir Dis 1988;138(2): 296-9
91. Eisner MD, Smith AK, Blanc PD. Bartenders' respiratory health after establishment of smoke-free bars and taverns. JAMA 1998;280(22): 1909-14
92. Orie NGM, Sluiter HJ, de Vries K, et al. The host factor in bronchitis. Bronchitis. An international symposium; 27-29 April 1960, University of Groningen. Royal Van Gorcum;1961. 43-59
93. Orie NG. The dutch hypothesis. Chest 2000;117(5 Suppl 1): 299S
94. Frey U, Suki B. Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control. Lancet 2008;372(9643): 1088-99
95. Postma DS, Kerkhof M, Boezen HM, Koppelman GH. Asthma and chronic obstructive pulmonary disease: common genes, common environments? Am J Respir Crit Care Med 2011;183(12): 1588-94
96. Tashkin DP, Altose MD, Connett JE, et al. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med 1996; 153(6 Pt 1): 1802-11
97. James AL, Palmer LJ, Kicic E, et al. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med 2005; 171(2): 109-14
98. Burgess JA, Walters EH, Byrnes GB, et al. Who remembers whether they had asthma as children? J Asthma 2006;43(10): 727-30
99. Sunyer J, Soriano J, Anto JM, et al. Sensitization to individual allergens as risk factors for lower FEV1 in young adults. European Community Respiratory Health Survey. Int J Epidemiol 2000;29(1): 125-30
100. Jaen A, Sunyer J, Basagana X, et al. Specific sensitization to common allergens and pulmonary function in the European Community Respiratory Health Survey. Clin Exp Allergy 2002;32(12): 1713-19
101. Apostol GG, Jacobs DR Jr, Tsai AW, et al. Early life factors contribute to the decrease in lung function between ages 18 and 40: the Coronary Artery Risk Development in Young Adults study. Am J Respir Crit Care Med 2002;166(2): 166-72
102. Sorheim IC, Johannessen A, Gulsvik A, et al. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax 2010;65(6): 480-5
103. Upton MN, Smith GD, McConnachie A, et al. Maternal and personal cigarette smoking synergize to increase airflow limitation in adults. Am J Respir Crit Care Med 2004;169(4): 479-87 • Describes a maternal-personal smoking interaction on pre-bronchodilator spirometry for middle-aged offspring.
104. Perret JL, Matheson MC, Gurrin LC, et al. Interactions between parental, adult passive smoking and complex lung function in middle age [abstract]. Respirology 2013; 18(Suppl 2): 22
105. Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011;365(13): 1184-92